What if a simple daily pill could cut your "bad" cholesterol level by more than half? That is the spectacular promise of enlicitide, an experimental drug developed by Merck whose clinical results, published in the New England Journal of Medicine in early 2026, have sent shockwaves through the world of cardiology. What exactly is enlicitide? ...